CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
OSL:CONTX - Oslo Bors ASA - SE0014731154 - Common Stock - Currency: NOK
We assign a fundamental rating of 6 out of 10 to CONTX. CONTX was compared to 12 industry peers in the Health Care Technology industry. CONTX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CONTX is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CONTX was profitable.
In the past year CONTX had a positive cash flow from operations.
CONTX had positive earnings in 4 of the past 5 years.
In the past 5 years CONTX always reported a positive cash flow from operatings.
1.2 Ratios
CONTX has a Return On Assets of 18.29%. This is amongst the best in the industry. CONTX outperforms 100.00% of its industry peers.
The Return On Equity of CONTX (22.76%) is better than 90.91% of its industry peers.
With an excellent Return On Invested Capital value of 22.31%, CONTX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CONTX is significantly above the industry average of 7.76%.
The 3 year average ROIC (57.27%) for CONTX is well above the current ROIC(22.31%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.29% | ||
| ROE | 22.76% | ||
| ROIC | 22.31% |
ROA(3y)18.09%
ROA(5y)14.73%
ROE(3y)21.7%
ROE(5y)18.28%
ROIC(3y)57.27%
ROIC(5y)47.93%
1.3 Margins
CONTX has a Profit Margin of 16.76%. This is in the better half of the industry: CONTX outperforms 72.73% of its industry peers.
CONTX's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 20.56%, CONTX belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
In the last couple of years the Operating Margin of CONTX has grown nicely.
CONTX's Gross Margin of 96.83% is amongst the best of the industry. CONTX outperforms 90.91% of its industry peers.
CONTX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.56% | ||
| PM (TTM) | 16.76% | ||
| GM | 96.83% |
OM growth 3Y-15.67%
OM growth 5Y136.77%
PM growth 3Y24.76%
PM growth 5YN/A
GM growth 3Y0.13%
GM growth 5Y0.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
CONTX has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CONTX remains at a similar level compared to 5 years ago.
CONTX has a worse debt/assets ratio than last year.
2.2 Solvency
The Debt to FCF ratio of CONTX is 0.05, which is an excellent value as it means it would take CONTX, only 0.05 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.05, CONTX belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
CONTX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
CONTX has a better Debt to Equity ratio (0.00) than 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | N/A |
ROIC/WACC3.33
WACC6.71%
2.3 Liquidity
CONTX has a Current Ratio of 4.64. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.64, CONTX belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
A Quick Ratio of 4.57 indicates that CONTX has no problem at all paying its short term obligations.
CONTX's Quick ratio of 4.57 is amongst the best of the industry. CONTX outperforms 90.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.64 | ||
| Quick Ratio | 4.57 |
3. Growth
3.1 Past
The earnings per share for CONTX have decreased strongly by -43.75% in the last year.
Measured over the past years, CONTX shows a very strong growth in Earnings Per Share. The EPS has been growing by 40.02% on average per year.
The Revenue has decreased by -1.27% in the past year.
Measured over the past years, CONTX shows a small growth in Revenue. The Revenue has been growing by 7.78% on average per year.
EPS 1Y (TTM)-43.75%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-46.15%
Revenue 1Y (TTM)-1.27%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-8.11%
3.2 Future
The Earnings Per Share is expected to decrease by -13.93% on average over the next years. This is quite bad
CONTX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.50% yearly.
EPS Next Y-28.88%
EPS Next 2Y-17.13%
EPS Next 3Y-13.93%
EPS Next 5YN/A
Revenue Next Year-5.88%
Revenue Next 2Y-1.11%
Revenue Next 3Y1.21%
Revenue Next 5Y3.5%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 18.14 indicates a rather expensive valuation of CONTX.
Compared to the rest of the industry, the Price/Earnings ratio of CONTX indicates a rather cheap valuation: CONTX is cheaper than 81.82% of the companies listed in the same industry.
CONTX is valuated rather cheaply when we compare the Price/Earnings ratio to 28.47, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 17.16, the valuation of CONTX can be described as rather expensive.
63.64% of the companies in the same industry are more expensive than CONTX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, CONTX is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.14 | ||
| Fwd PE | 17.16 |
4.2 Price Multiples
CONTX's Enterprise Value to EBITDA is on the same level as the industry average.
90.91% of the companies in the same industry are more expensive than CONTX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.78 | ||
| EV/EBITDA | 8.85 |
4.3 Compensation for Growth
The excellent profitability rating of CONTX may justify a higher PE ratio.
A cheap valuation may be justified as CONTX's earnings are expected to decrease with -13.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.13%
EPS Next 3Y-13.93%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
CONTX's Dividend Yield is a higher than the industry average which is at 3.80.
CONTX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CONTX pays out 53.39% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP53.39%
EPS Next 2Y-17.13%
EPS Next 3Y-13.93%
CONTEXTVISION AB
OSL:CONTX (2/4/2025, 7:00:00 PM)
5.08
-0.1 (-1.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners15.68%
Inst Owner ChangeN/A
Ins Owners25.32%
Ins Owner ChangeN/A
Market Cap393.04M
Analysts84.44
Price Target6.12 (20.47%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP53.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.39%
Min EPS beat(2)-55.87%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-29.91%
Min EPS beat(4)-67.64%
Max EPS beat(4)6.8%
EPS beat(8)4
Avg EPS beat(8)-14.18%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.62%
Min Revenue beat(2)-4.67%
Max Revenue beat(2)-0.57%
Revenue beat(4)1
Avg Revenue beat(4)-4.68%
Min Revenue beat(4)-14.25%
Max Revenue beat(4)0.79%
Revenue beat(8)4
Avg Revenue beat(8)0.1%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-12.12%
EPS NY rev (3m)-12.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.29%
Revenue NY rev (3m)-2.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.14 | ||
| Fwd PE | 17.16 | ||
| P/S | 2.95 | ||
| P/FCF | 10.78 | ||
| P/OCF | 12.86 | ||
| P/B | 4.01 | ||
| P/tB | 4.19 | ||
| EV/EBITDA | 8.85 |
EPS(TTM)0.28
EY5.51%
EPS(NY)0.3
Fwd EY5.83%
FCF(TTM)0.47
FCFY9.28%
OCF(TTM)0.39
OCFY7.77%
SpS1.72
BVpS1.27
TBVpS1.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.29% | ||
| ROE | 22.76% | ||
| ROCE | 27.81% | ||
| ROIC | 22.31% | ||
| ROICexc | 111.28% | ||
| ROICexgc | 142.24% | ||
| OM | 20.56% | ||
| PM (TTM) | 16.76% | ||
| GM | 96.83% | ||
| FCFM | 27.38% |
ROA(3y)18.09%
ROA(5y)14.73%
ROE(3y)21.7%
ROE(5y)18.28%
ROIC(3y)57.27%
ROIC(5y)47.93%
ROICexc(3y)164.82%
ROICexc(5y)128.08%
ROICexgc(3y)288.21%
ROICexgc(5y)248.2%
ROCE(3y)71.37%
ROCE(5y)59.72%
ROICexcg growth 3Y-6.04%
ROICexcg growth 5Y137.12%
ROICexc growth 3Y15.41%
ROICexc growth 5Y157.51%
OM growth 3Y-15.67%
OM growth 5Y136.77%
PM growth 3Y24.76%
PM growth 5YN/A
GM growth 3Y0.13%
GM growth 5Y0.11%
F-Score5
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 70.92% | ||
| Cap/Sales | 4.44% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85.56% | ||
| Profit Quality | 163.4% | ||
| Current Ratio | 4.64 | ||
| Quick Ratio | 4.57 | ||
| Altman-Z | N/A |
F-Score5
WACC6.71%
ROIC/WACC3.33
Cap/Depr(3y)35.39%
Cap/Depr(5y)63.46%
Cap/Sales(3y)3.16%
Cap/Sales(5y)8.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.75%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-46.15%
EPS Next Y-28.88%
EPS Next 2Y-17.13%
EPS Next 3Y-13.93%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.27%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-8.11%
Revenue Next Year-5.88%
Revenue Next 2Y-1.11%
Revenue Next 3Y1.21%
Revenue Next 5Y3.5%
EBIT growth 1Y-42.03%
EBIT growth 3Y-5.77%
EBIT growth 5Y155.18%
EBIT Next Year-13.93%
EBIT Next 3Y0.14%
EBIT Next 5YN/A
FCF growth 1Y98.32%
FCF growth 3Y47.23%
FCF growth 5YN/A
OCF growth 1Y16.99%
OCF growth 3Y26.1%
OCF growth 5Y54.28%